Literature DB >> 26958819

Perception of the value of generic drugs in São Paulo, Brazil.

Elene Paltrinieri Nardi1, Marcos Bosi Ferraz1.   

Abstract

The objective of this study was to assess the perceptions of opinion-leaders, patients and their accompanying family members or carers about generic drugs. Three groups of participants were surveyed: (i) 50 customers while they were visiting commercial pharmacies located in São Paulo city, Brazil, (ii) 25 patients and 25 companions while they were waiting at the university outpatient clinic, and (iii) 50 healthcare opinion-leaders from government, hospitals, health plans, academia, and pharmaceutical companies. The questions explored socio-demographic characteristics and perceptions regarding value attributes of generic drugs compared to brand name drugs. Respondents had an average age of 52 years and 53% were women. Respondents believed generic drugs to be cheaper than brand name drugs (97%), and 31% thought generic drugs to be less effective than brand name drugs. Also, generic drugs were perceived by 54% of respondents to be as safe as brand name drugs and 74% would prefer brand name drugs if there was no price difference. In conclusion, multiple factors may contribute to the decision to buy generic drugs; among these, perceived effectiveness, safety and price appear to be the most important factors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26958819     DOI: 10.1590/0102-311X00038715

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Attitude and Purchase Intention to Generic Drugs.

Authors:  Ricardo Arcaro; Cássia Rita Pereira da Veiga; Wesley Vieira da Silva; Claudimar Pereira da Veiga
Journal:  Int J Environ Res Public Health       Date:  2021-04-26       Impact factor: 3.390

2.  Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city.

Authors:  Marília Cruz Guttier; Marysabel Pinto Telis Silveira; Vera Lucia Luiza; Andréa Dâmaso Bertoldi
Journal:  Rev Saude Publica       Date:  2017-06-26       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.